STORAGE NAME: h1545a.HCB
DATE: 4/8/2025
1
FLORIDA HOUSE OF REPRESENTATIVES
BILL ANALYSIS
This bill analysis was prepared by nonpartisan committee staff and does not constitute an official statement of legislative intent.
BILL #: CS/HB 1545
TITLE: Parkinson's Disease Research Funding
SPONSOR(S): Busatta
COMPANION BILL: CS/SB 1800 (Calatayud)
LINKED BILLS: HB 1547 (Busatta)
RELATED BILLS: None
Committee References
Health Professions & Programs
17 Y, 0 N, As CS
Health Care Budget
Health & Human Services
SUMMARY
Effect of the Bill:
The bill creates the Consortium for Parkinson’s Disease Research within the University of South Florida to conduct
research on the causes, mechanisms, and potential treatment for Parkinson’s disease and the prevalence of
Parkinson’s disease in first responders. The bill also establishes the Parkinson’s Disease Research Board to manage
the Consortium.
Fiscal or Economic Impact:
The bill appropriates $8 million in recurring funds from the General Revenue Fund to the University of South
Florida for Parkinson’s disease research and $4 million in recurring funds for the Consortium’s Parkinson’s disease
research for the 2025-2026 Fiscal year.
JUMP TO SUMMARY ANALYSIS RELEVANT INFORMATION BILL HISTORY
ANALYSIS
EFFECT OF THE BILL:
Florida law does not provide funding or guidelines for Parkinson’s disease research. Current law only provides that
the Department of Health and the Florida Public Health Institute, Inc. must include Parkinson’s disease during its
monthly public health awareness campaigns on preventing, detecting, treating, and curing diseases at least once
within a two-year period.
1
Consortium for Parkinson’s Disease Research
The bill creates the Consortium for Parkinson’s Disease Research (Consortium). The Consortium is established
within the University of South Florida and is comprised of public and private universities. The bill provides that the
universities within the Consortium research Parkinson’s disease’s causes, mechanisms, and treatments and the
prevalence of Parkinson’s disease in first responders. (Section 1).
The bill establishes a director of the Consortium, who is appointed by the Parkinson’s Disease Research Board
(Board), to administer the Consortium. The director must:
Prepare a research plan that describes how the Consortium’s research will contribute to knowledge of
Parkinson’s disease’s causes, mechanisms, and treatments and prevalence in first responders, and
submit it to the Board;
Identify the Consortium’s priority research projects;
Recruit public and private universities researching Parkinson’s disease to participate in the
Consortium;
Propose the Consortium’s budget;
1
S. 381.981, F.S. JUMP TO SUMMARY ANALYSIS RELEVANT INFORMATION BILL HISTORY
2
Apply for research grants;
Encourage collaboration between scientists, researchers, and other appropriate personnel within the
Consortium’s charter; and
Perform any other duties determined by the Board. (Section 1).
Parkinson’s Disease Research Board
The bill creates the Parkinson’s Disease Research Board to manage the Consortium’s operations. Each year, the
Board must adopt a Parkinson’s disease research plan. The board may adopt the Consortium’s recommendation or
create its own plan, provided it describes how the Consortium’s research will contribute to knowledge of
Parkinson’s disease’s causes, mechanisms, and treatments and the prevalence of Parkinson’s disease in first
responders. (Section 1).
The bill allocates $4 million in recurring funds from the General Revenue Fund to the University of South Florida
for the Consortium. (Section 2). The Board must provide funds to the Consortium’s members that is consistent with
the Board’s plan. (Section 1).
The bill requires the Board to submit an annual report to the Governor, President of the Senate, and the Speaker of
the House by October 15 of each year describing the Consortium’s current research projects and findings,
community outreach initiatives, and future research programs. (Section 1).
The Board may create, amend, and repeal a charter to govern itself. The Board must select a chair from among its
members who will serve a two-year term. All of the Board’s actions require a majority vote of present members.
The Board must meet at least semiannually, and four members constitute a quorum. (Section 1).
The Board consists of members representing participating universities. Each president of the participating
universities appoints a member. The bill requires members to have experience in scientific fields, such as
neurology, psychology, nutrition, and genetics. Members serve a four-year term and may be reappointed. (Section
1).
Members may not receive compensation for their role. However, they may be reimbursed for travel expenses by
the Consortium or the Board, provided the costs are authorized, necessarily incurred, and follow the rates of per
diem requirements in s. 112.061, F.S..
2 (Section 1).
FISCAL OR ECONOMIC IMPACT:
STATE GOVERNMENT:
The bill allocates $8 million in recurring funds from the General Revenue Fund to the University of South Florida
for Parkinson’s disease research, including at a minimum, research related to the disease’s genetic origin and
therapeutic interventions to slow disease progression. (Section 2).
The bill allocates $4 million in recurring funds from the General Revenue Fund to the University of South Florida
for the Consortium for Parkinson’s Disease Research. (Section 2).
The bill provides an effective date of July 1, 2025. (Section 3).
RELEVANT INFORMATION
SUBJECT OVERVIEW:
Parkinson’s Disease
2
S. 112.061, F.S. JUMP TO SUMMARY ANALYSIS RELEVANT INFORMATION BILL HISTORY
3
Parkinson’s disease is a progressive neurological disorder that impacts an individual’s nervous system and causes
unintended and slow movements, such as tremors, stiffness, and difficulty with balance.
3 Individuals with
Parkinson’s disease may have trouble walking, talking, and completing day-to-day tasks.
The exact cause of Parkinson’s disease is unknown.
4 However, some studies have shown that Parkinson’s disease is
partially caused by damaged or dead neurons within the substantia nigra, which is an area of the brain that
controls movement.
5 The neurons in this area produce dopamine that send signals to parts of the body to complete
movements. However, neurons reduce their dopamine production when they become damaged or die, resulting in
limited movement control. Neurons may become damaged from buildup of protein particles, called Lewy Bodies,
that are not properly disposed of within brain cells.
Some studies have also indicated that Parkinson’s disease may be genetic. About 10 to 15 percent of Parkinson’s
disease is caused by genetics.
6 Seven genes are linked to causing or increasing the risk of being diagnosed with
Parkinson’s disease.
7 However, additional genes and environmental factors largely impact whether a genetic code
leads to a diagnosis. Genetic testing is a recent development in Parkinson’s disease research, and research on
genetic origins is underdeveloped.
There is no cure for Parkinson’s disease.
8 However, treatments and therapies can relieve some symptoms.
9 Most
treatments focus on restoring dopamine in the brain through prescription medicines.
10 Individuals who cannot
manage their symptoms through medication may seek relief through deep brain stimulation.
11 Deep brain
stimulation requires surgical implants in a patient’s brain and chest to facilitate electrodes stimulating affected
parts of the brain.
Approximately one million Americans are affected by Parkinson’s disease, with an estimated 90,000 new diagnoses
each year.
12 Florida has the highest percentage of state population with Parkinson’s disease, with the disease
impacting about 79,990 Floridians.
13 The primary risk factor is age, with Parkinson’s disease risk increasing
around ages 65-years and older.
14 About 21 percent of Floridian’s population is 65-years or older, the second
highest in the U.S.
15
Current Status of Parkinson’s Disease Research
The Parkinson’s Foundation designates the U.S.’ top medical centers with specialized teams focused on Parkinson’s
disease clinical research and care as “Centers of Excellence.”
16 Florida is home to three Parkinson’s disease Centers
of Excellence, including the University of South Florida Parkinson’s Disease & Movement Disorders Center, the
3
National Institute of Neurological Disorders and Stroke, Parkinson’s Disease (Mar. 5, 2025). Available at
https://www.ninds.nih.gov/health-information/disorders/parkinsons-disease (last visited Mar. 19, 2025).
4
National Institute on Aging, Parkinson’s Disease: Causes, Symptoms, and Treatments (April 14, 2022). Available at
https://www.nia.nih.gov/health/parkinsons-disease/parkinsons-disease-causes-symptoms-and-treatments (last visited Mar.
19, 2025).
5
Supra note 3.
6
Parkinson’s Foundation, Statistics, https://www.parkinson.org/understanding-parkinsons/statistics (last visited Mar. 20,
2025).
7
National Human Genome Research Institute, About Parkinson’s Disease. Available at About Parkinson's Disease (last visited
Mar. 19, 2025).
8
Supra note 4.
9
Id.
10
Roger A. Barker and Thomas B Stoker, Recent developments in the treatment of Parkinson's Disease (Jul. 31, 2020). Available
at https://pmc.ncbi.nlm.nih.gov/articles/PMC7400683/ (last visited Mar. 19, 2025).
11
Supra note 4.
12
Supra note 6.
13
Parkinson’s Association of Southwest Florida, Florida Parkinson Rate, Available at
https://parkinsonassociationswfl.org/parkinson-disease-in-florida.html (last visited Mar. 24, 2025).
14
Supra note 6.
15
Population Reference Bureau, States Ranked by Percent of Population (2020). Available at
https://www.prb.org/resources/which-us-states-are-the-oldest/ (last visited Mar. 20, 2025).
16
Parkinson’s Foundation, Centers of Excellence. Available at https://www.parkinson.org/living-with-parkinsons/finding-
care/global-care-network (last visited Mar. 24, 2025). JUMP TO SUMMARY ANALYSIS RELEVANT INFORMATION BILL HISTORY
4
University of Florida Movement Disorders and Neurorestoration Program, and the University of Miami Miller
School of Medicine.
17 Comparatively, California is home to five Centers of Excellence, New York is home to four, and
Texas is home to one.
18
The University of South Florida Parkinson’s Disease & Movement Disorders Center is the only center in Florida
primarily focused on Parkinson’s disease research and treatment. The center currently offers multiple clinical
trials to improve symptoms of early untreated Parkinson’s disease, test innovative treatments, and study the
disease’s causes and progression.
19
The University of Florida Movement Disorders and Neurorestoration Program operates within UF Health’s Norman
Fixel Institute for Neurological Diseases and studies a variety of neurological disorders, including amyotrophic
later sclerosis (ALS), dementia, Alzheimer’s disease, and Parkinson’s disease.
20 Currently, the Program offers only
two clinical trials for Parkinson’s disease research.
21 The Program’s Parkinson’s disease research focuses on
cognitive behavior and emotion, speech production, breathing and swallowing dysfunction, and development of
deep brain stimulation.
22
The University of Miami Miller School of Medicine does not have a program specifically designated for researching
Parkinson’s disease. However, the Miller School of Medicine’s John P. Hussman Institute for Human Genomics
researches Parkinson’s disease’s genetic causes, along with other genetic disorders such as Autism and Alzheimer’s
disease.
23 The Institute does not study Parkinson’s disease beyond its genetic causes. The Miller School of Medicine
also partners with the American Parkinson Disease Association’s (APDA) to host the APDA’s Information and
Referral Center.
24 The Center operates a telephone helpline, provides resources on symptoms and therapies, and
connects patients with physicians and specialists.
25
There is no indication that the three Florida Parkinson’s disease research centers and programs collaborate with
one another, share data, or form a consortium.
17
Parkinson’s Foundation, Florida Chapter. Available at https://www.parkinson.org/florida/florida-chapter#florida-chapter
(last visited Mar. 24, 2025).
18
Supra note 16.
19
USF Health, Parkinson’s Disease & Movement Disorders Center, Overview. Available at
https://health.usf.edu/care/neurology/services-specialties/parkinsons (last visited Mar. 24, 2025).
20
UF Health, Norman Fixel Institute for Neurological Diseases, Movement Disorders & Neurorestoration Program, About.
Available at https://movementdisorders.ufhealth.org/about/ (last visited Mar. 24, 2025); UF Health, Norman Fixel Institute
for Neurological Diseases, Movement Disorders & Neurorestoration Program, Clinical Trials. Available at
https://fixel.ufhealth.org/research-2/clinical-trials-2/ (last visited Mar. 24, 2025).
21
UF Health, Parkinson Disease Clinical Trials. Available at https://ufhealth.org/conditions-and-treatments/parkinson-
disease/clinical-trials (last visited Mar. 24, 2025).
22
UF Health, Norman Fixel Institute for Neurological Diseases, Movement Disorders & Neurorestoration Program, Clinical
Research. Available at https://movementdisorders.ufhealth.org/research/clinical-research/ (last visited Mar. 24, 2025).
23
University of Miami Miller School of Medicine, John P. Hussman Institute for Human Genomics, Parkinson Disease. Available
at https://med.miami.edu/centers-and-institutes/hihg/research-programs/parkinson-disease (last visited Mar. 24, 2025).
24
University of Miami Miller School of Medicine, New Center Expands Services to Parkinson’s Disease Community, Targeting
Underserved Spanish-Speaking Population (April 28, 2021). https://news.med.miami.edu/new-center-expands-services-to-
parkinsons-disease-community-targeting-underserved-spanish-speaking-
population/#:~:text=The%20Miller%20School%20is%20a%20Parkinson%E2%80%99s%20Fou ndation%20Center,treatme
nts%20and%20research%20while%20providing%20the%20best%20care (last visited Mar. 24, 2025).
25
American Parkinson’s Disease Association, ADPA’s Grassroots Network: ADPA Information & Referral Centers (Mar. 21, 2021).
Available at https://www.apdaparkinson.org/article/our-network-of-information-and-referral-centers/ (last visited Mar. 24,
2025). JUMP TO SUMMARY ANALYSIS RELEVANT INFORMATION BILL HISTORY
5
BILL HISTORY
COMMITTEE REFERENCE ACTION DATE
STAFF
DIRECTOR/
POLICY CHIEF
ANALYSIS
PREPARED BY
Health Professions & Programs
Subcommittee
17 Y, 0 N, As CS 3/27/2025 McElroy Cook
THE CHANGES ADOPTED BY THE
COMMITTEE:
Health Care Budget Subcommittee Clark Day
Health & Human Services
Committee
-------------------------------------------------------------------------------------------------------------------------------------
THIS BILL ANALYSIS HAS BEEN UPDATED TO INCORPORATE ALL OF THE CHANGES DESCRIBED ABOVE.
-------------------------------------------------------------------------------------------------------------------------------------